April 29, 2016 6:53 AM ET


Company Overview of Galera Therapeutics, Inc.

Executive Profile

J. Mel Sorensen M.D.

Chief Executive Officer, President and Director, Galera Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 4 different industries.

See Board Relationships


Dr. J. Mel Sorensen, M.D., serves as the Chief Executive Officer and President of Galera Therapeutics, Inc. Dr. Sorensen was the Chief Executive Officer, President, Director and Chairman of Ascenta Shanghai R&D Center at Ascenta Therapeutics Inc., since joining in August 2004. He is a highly experienced leader and administrator in cancer therapeutics and cancer drug development. Trained as a medical oncologist, he has dedicated his career to clinical cancer research ...

Corporate Headquarters

2 West Liberty Boulevard
Malvern, Pennsylvania 19355

United States

Phone: 610-725-1500
Fax: --

Board Members Memberships

Chief Executive Officer, President and Director


There is no Education data available.

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Galera Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.